Literature DB >> 19934428

Therapeutic innovations, diminishing returns, and control rate preservation.

David M Kent1, Thomas A Trikalinos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19934428      PMCID: PMC3063072          DOI: 10.1001/jama.2009.1679

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

Review 1.  Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

Authors:  Ignacio Ferreira-González; Jason W Busse; Diane Heels-Ansdell; Victor M Montori; Elie A Akl; Dianne M Bryant; Pablo Alonso-Coello; Jordi Alonso; Andrew Worster; Suneel Upadhye; Roman Jaeschke; Holger J Schünemann; Gaietà Permanyer-Miralda; Valeria Pacheco-Huergo; Antònia Domingo-Salvany; Ping Wu; Edward J Mills; Gordon H Guyatt
Journal:  BMJ       Date:  2007-04-02

2.  The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction.

Authors:  Peter A Kavsak; Andrew R MacRae; Viliam Lustig; Rakesh Bhargava; Rudy Vandersluis; Glenn E Palomaki; Marie-Jeanne Yerna; Allan S Jaffe
Journal:  Am Heart J       Date:  2006-07       Impact factor: 4.749

Review 3.  Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction.

Authors:  A J Nordmann; H Bucher; P Hengstler; T Harr; J Young
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

4.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

5.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

Authors:  Marc S Sabatine; Christopher P Cannon; C Michael Gibson; Jose L López-Sendón; Gilles Montalescot; Pierre Theroux; Marc J Claeys; Frank Cools; Karen A Hill; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-03-09       Impact factor: 91.245

6.  Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE).

Authors:  K A A Fox; S G Goodman; W Klein; D Brieger; P G Steg; O Dabbous; A Avezum
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

7.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

Review 8.  Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.

Authors:  Thomas A Trikalinos; Alawi A Alsheikh-Ali; Athina Tatsioni; Brahmajee K Nallamothu; David M Kent
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

View more
  8 in total

Review 1.  Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes.

Authors:  Issa J Dahabreh; Radley C Sheldrick; Jessica K Paulus; Mei Chung; Vasileia Varvarigou; Haseeb Jafri; Jeremy A Rassen; Thomas A Trikalinos; Georgios D Kitsios
Journal:  Eur Heart J       Date:  2012-06-17       Impact factor: 29.983

2.  The new heart failure diet: less salt restriction, more micronutrients.

Authors:  Michael B Rothberg; Senthil K Sivalingam
Journal:  J Gen Intern Med       Date:  2010-10       Impact factor: 5.128

3.  Aggregating and disaggregating patients in clinical trials and their subgroup analyses.

Authors:  David M Kent; Peter K Lindenauer
Journal:  Ann Intern Med       Date:  2010-07-06       Impact factor: 25.391

4.  Searching the clinical fitness landscape.

Authors:  Margaret J Eppstein; Jeffrey D Horbar; Jeffrey S Buzas; Stuart A Kauffman
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 5.  Critical Limb Ischemia: Current Trends and Future Directions.

Authors:  Martin Teraa; Michael S Conte; Frans L Moll; Marianne C Verhaar
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

6.  Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials.

Authors:  Melissa C W Vaanholt; Marlies M Kok; Clemens von Birgelen; Marieke G M Weernink; Janine A van Til
Journal:  Health Expect       Date:  2018-08-14       Impact factor: 3.377

7.  The Burden of the "False-Negatives" in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures.

Authors:  T Burt; K S Button; Hhz Thom; R J Noveck; M R Munafò
Journal:  Clin Transl Sci       Date:  2017-07-04       Impact factor: 4.689

8.  Communicating Uncertainty in Written Consumer Health Information to the Public: Parallel-Group, Web-Based Randomized Controlled Trial.

Authors:  Roland B Büchter; Cornelia Betsch; Martina Ehrlich; Dennis Fechtelpeter; Ulrich Grouven; Sabine Keller; Regina Meuer; Constanze Rossmann; Andreas Waltering
Journal:  J Med Internet Res       Date:  2020-08-10       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.